HHS Overview

Dorchester Minerals Insider Purchase: CFO Leslie A. Moriyama purchased 12,050 shares of DMLP for $414,640 at $34.41 each, while the stock is currently trading lower at $33.00, indicating a potential buying opportunity for investors.

Harte Hanks Insider Purchase: Director Bradley Louis Radoff bought 42,775 shares of Harte Hanks for $241,551 at $5.65 each, with the stock up about 3.6% on Friday, reflecting an 8.0% gain based on current trading prices.

Earnings Performance: Harte-Hanks reported quarterly earnings of $0.13 per share, exceeding estimates and showing a year-over-year increase from $0.08. The company also surpassed revenue expectations with $47.63 million for the quarter.

Market Outlook: Despite recent earnings success, Harte-Hanks shares have underperformed compared to the S&P 500 this year, and the stock currently holds a Zacks Rank #3 (Hold), indicating expected performance in line with the market.

Earnings Performance: Integral Ad Science (IAS) reported quarterly earnings of $0.10 per share, exceeding estimates and showing improvement from a loss of $0.09 per share a year ago, although revenues fell short of expectations at $133.53 million.

Market Outlook: IAS shares have underperformed the market this year, with a Zacks Rank of #3 (Hold), indicating expected performance in line with the market; future stock movements will depend on management's commentary and earnings estimate revisions.

Harte-Hanks Stock Performance: Harte-Hanks (HHS) closed at $6.98, unchanged from the previous day, while experiencing a 5.55% loss over the past month, underperforming compared to the Business Services sector and S&P 500 gains. The company is set to release its earnings report on November 14, 2024, with expectations of a 25% year-over-year growth in earnings.

Analyst Estimates and Zacks Rank: The Zacks Consensus Estimates predict a significant decline in annual earnings and revenue for Harte-Hanks, currently holding a Zacks Rank of #3 (Hold). The Zacks Rank system indicates that stocks rated #1 (Strong Buy) have historically outperformed others, suggesting potential investment strategies based on analyst estimate changes.